| NCT07024589 | First-in-Human Trial of Oral AN2-502998 | RECRUITING | PHASE1 | 2025-08-04 | 2025-12 | 2025-12 |
| NCT05995444 | A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects | COMPLETED | PHASE1 | 2023-06-05 | 2023-08-03 | 2023-07-26 |
| NCT05327803 | Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease | TERMINATED | PHASE2, PHASE3 | 2022-05-20 | 2024-12-18 | 2024-12-18 |
| NCT05283746 | A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function | COMPLETED | PHASE1 | 2022-02-21 | 2022-06-27 | 2022-06-10 |
| NCT04892641 | Phase 1 Study of Epetraborole Tablets | COMPLETED | PHASE1 | 2021-06-10 | 2022-02-26 | 2022-02-26 |